New hope for Tough-to-Treat blood cancer
Disease control
Recruiting now
This early-stage trial is testing the safety and early effectiveness of a new three-drug combination for adults whose acute myeloid leukemia (AML) has returned after prior treatment. The study will first find the safest dose and then look for signs that the treatment can help con…
Phase: PHASE1 • Sponsor: Douglas Tremblay • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC